Celyad SA Valuation
| CYAD Stock | EUR 0.77 0.01 1.28% |
Celyad SA is overvalued. Celyad SA shows a prevailing Real Value of €0.7 per share. The current price of the firm is €0.77. Our model approximates the value of Celyad SA from analyzing the firm fundamentals such as Current Valuation of 11.19 M, shares owned by insiders of 8.83 %, and Return On Equity of -0.93 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Celyad SA's price fluctuation is out of control at this time. Calculation of the real value of Celyad SA is based on 3 months time horizon. Increasing Celyad SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Celyad stock is determined by what a typical buyer is willing to pay for full or partial control of Celyad SA. Since Celyad SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Celyad Stock. However, Celyad SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.77 | Real 0.7 | Hype 0.77 |
The intrinsic value of Celyad SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Celyad SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Celyad SA helps investors to forecast how Celyad stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Celyad SA more accurately as focusing exclusively on Celyad SA's fundamentals will not take into account other important factors: Celyad SA Total Value Analysis
Celyad SA is currently projected to have takeover price of 11.19 M with market capitalization of 28.29 M, debt of 3.4 M, and cash on hands of 12.13 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Celyad SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.19 M | 28.29 M | 3.4 M | 12.13 M |
Celyad SA Asset Utilization
One of the ways to look at asset utilization of Celyad is to check how much profit was generated for every dollar of assets it reports. Celyad SA shows a negative utilization of assets of -0.29 percent, losing €0.002933 for each euro of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each euro of assets it shows. Put another way, asset utilization of Celyad SA shows how discouraging it operates for each euro spent on its assets.Celyad SA Ownership Allocation
Celyad SA holds a total of 22.59 Million outstanding shares. Celyad SA shows 8.83 percent of its outstanding shares held by insiders and 24.19 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Celyad SA Profitability Analysis
Net Loss for the year was (26.51 M) with profit before overhead, payroll, taxes, and interest of 5 K.About Celyad SA Valuation
The stock valuation mechanism determines Celyad SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Celyad SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Celyad SA. We calculate exposure to Celyad SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Celyad SA's related companies.Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor-T cell-based therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. CELYAD ONCOLOGY operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 87 people.
8 Steps to conduct Celyad SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Celyad SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Celyad SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Celyad SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Celyad SA's revenue streams: Identify Celyad SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Celyad SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Celyad SA's growth potential: Evaluate Celyad SA's management, business model, and growth potential.
- Determine Celyad SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Celyad SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Celyad Stock Analysis
When running Celyad SA's price analysis, check to measure Celyad SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad SA is operating at the current time. Most of Celyad SA's value examination focuses on studying past and present price action to predict the probability of Celyad SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad SA's price. Additionally, you may evaluate how the addition of Celyad SA to your portfolios can decrease your overall portfolio volatility.